HCQ prophylaxis in COVID-19 did not show any QTc prolongation in Healthcare workers

Jha, S; Batra, N; Siddiqui, S; Yadav, A; Misra, A; Loomba, M; Sethi, S; Waghdhare, S

Jha, S (corresponding author), Max Healthcare, Inst Endocrinol Diabet & Metab, New Delhi, India.

INDIAN HEART JOURNAL, 2021; 73 (1): 74

Abstract

Background: HCQ is a commonly recommended drug for the prophylaxis of COVID-19. One of its rare side-effect includes QTc prolongation. Methods: This w......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索